Neel VarshneyBoard Member, Enavate Sciences
Founding Partner, Patient Square Capital
Neel Varshney, M.D. is a Founding Partner of Patient Square Capital. He has over 15 years of investment and health care experience. Prior to Patient Square, Dr. Varshney was a Managing Director within KKR’s Americas Health Care Team, where he focused on health care private and growth equity. Prior to joining KKR in 2016, he was a Vice President at Linden Capital Partners, focused exclusively on health care. Earlier in his career, Dr. Varshney was an Engagement Manager at McKinsey & Company in the health care, private equity, and corporate finance practices and worked in business development at Medtronic. He trained in internal medicine at Massachusetts General Hospital (MGH), a Harvard academic teaching hospital, where he cared for patients.
In addition to Enavate Sciences and Apollo Therapeutics, Dr. Varshney has served on the Boards of Directors of companies across health care sectors and stages, including Ajax Health, BrightSpring Pharmerica, CORPAK MedSystems, Envision Healthcare, EPIX Therapeutics, Headlands Research, Slayback Pharma, and Virtus Pharmaceuticals.
Dr. Varshney holds a B.S. in Electrical Engineering from the University of Alabama at Birmingham (UAB) and M.D. with Honors from Harvard Medical School and MIT in the Health Sciences and Technology (HST) program. He also holds an M.Sc. in Neuroscience from the University of Oxford. Dr. Varshney is a Soros Fellow and Rhodes Scholar.